Article
Hepatitis C virus diversity and treatment outcomes in Benin: a prospective cohort study.
The Lancet. Microbe - 1 Jul 2024
Ahovègbé Lucrèce, Shah Rajiv, Kpossou Aboudou Raïmi, Davis Chris, Niebel Marc, Filipe Ana, Goldstein Emily, Alassan Khadidjatou S, Keke René, Sehonou Jean, Kodjoh Nicolas, Gbedo Sossa Edmond, Ray Surajit, Wilkie Craig, Vattipally Sreenu, Tong Lily, Kamba Pakoyo F, Gbenoudon S Judith, Gunson Rory, Ogwang Patrick, Thomson Emma C
Abstract excerpt
BACKGROUND: 10 million people are chronically infected with the hepatitis C virus (HCV) in sub-Saharan Africa. The assessment of viral genotypes and treatment response in this region is necessary to achieve the WHO target of worldwide elimination of viral hepatitis by 2030. We aimed to investigate the prevalence of HCV genotypes and outcomes of treatment with direct-acting antiviral agents in Benin, a country...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
